75 related articles for article (PubMed ID: 3188630)
1. [Possibilities of using anti-HLA sera in modulating the functional properties of lymphocytes and passive immunotherapy].
Levin VI; Soloveĭ AN; Atamanenko LG; Pilotovich VS; San'ko NM
Vestn Akad Med Nauk SSSR; 1988; (7):57-62. PubMed ID: 3188630
[No Abstract] [Full Text] [Related]
2. [Natural HLA-A, B and DR antibodies in the serum of non-immunized men].
Májský A
Vnitr Lek; 1989 May; 35(5):467-71. PubMed ID: 2763480
[TBL] [Abstract][Full Text] [Related]
3. [Antibody response to histocompatibility antigens in hemodialysis patients subjected to planned whole-blood transfusions].
Fagiolo U; Corsano A; Antonello A; Venturi-Pasini C; Dal Lago O; Indiveri F
Minerva Chir; 1980 May; 35(10):701-4. PubMed ID: 7005724
[TBL] [Abstract][Full Text] [Related]
4. Association between long-term kidney graft survival and the presence of pre-transplant cytotoxic anti-HLA and/or non-MHC 'Fc gamma RII blocking' (anti-TLX) alloantibody.
Padányi A; Gyódi E; Rajczy K; Perner F; Petrányi GG
Clin Transplant; 1996 Oct; 10(5):455-60. PubMed ID: 8930462
[TBL] [Abstract][Full Text] [Related]
5. [Passive immunotherapy using anti-HLA antibodies in the treatment of patients with nephrotic syndrome].
Savchenko NE; Levin VI; Pilotovich VS; Pivovarova IV; Fateeva NG
Klin Med (Mosk); 1989 Feb; 67(2):67-70. PubMed ID: 2724891
[No Abstract] [Full Text] [Related]
6. The influence of HLA-A and -B matched blood transfusions on immune response.
Giacchino F; Coppo R; Giraudo G; Piccoli G
Clin Nephrol; 1983 Jun; 19(6):322-3. PubMed ID: 6347493
[No Abstract] [Full Text] [Related]
7. Cross-reactive antigens and HLA matching.
Scornik JC
Transplant Proc; 1987 Feb; 19(1 Pt 1):693-5. PubMed ID: 3274845
[TBL] [Abstract][Full Text] [Related]
8. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
[TBL] [Abstract][Full Text] [Related]
9. HLA-A antigen incompatibility and HLA-B antigen compatibility associated with enhanced kidney allograft survival in blood-transfused patients.
Bućin D
Exp Clin Immunogenet; 1986; 3(3):138-44. PubMed ID: 3274633
[TBL] [Abstract][Full Text] [Related]
10. A reevaluation of the putative association between the Fc gamma receptor and histocompatibility antigens on human mononuclear leukocytes.
Pulleyblank BM; Falk JA; Letarte M; Dorrington KJ; Falk RE
J Immunol; 1982 Jun; 128(6):2810-5. PubMed ID: 6210736
[TBL] [Abstract][Full Text] [Related]
11. [Post-transfusional anti-HLA hyperimmunization: importance of erythropoietin].
Mourad G; Chong G; Cristol JP; Lorho R; Ramounau-Pigot A; Seignalet J
Nephrologie; 1993; 14(2):91-4. PubMed ID: 8327032
[TBL] [Abstract][Full Text] [Related]
12. Neonatal alloimmune thrombocytopenia due to anti-human leukocyte antigen antibody: a case report.
Sasaki M; Yagihashi A; Kobayashi D; Watanabe N; Fujikawa T; Chiba S; Sato S; Morishita K; Sekimoto T; Ikeda H
Pediatr Hematol Oncol; 2001 Dec; 18(8):519-24. PubMed ID: 11764101
[TBL] [Abstract][Full Text] [Related]
13. Humoral immunity in renal transplantation Detection of cytotoxic antibodies to lymphocyte antigens other than HLA-A,B,C and Ia-like antigens in patients with vascular graft rejection.
Lordon RE; Wilson RL; Shield CF; Ferrone S
Transplantation; 1981 Oct; 32(4):286-90. PubMed ID: 7036445
[TBL] [Abstract][Full Text] [Related]
14. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
[TBL] [Abstract][Full Text] [Related]
15. Ethnic differences in HLA antigens in Chilean donors and recipients: data from the National Renal Transplantation Program.
Droguett MA; Beltran R; Ardiles R; Raddatz N; Labraña C; Arenas A; Flores J; Alruiz P; Mezzano S; Ardiles L
Transplant Proc; 2008 Nov; 40(9):3247-50. PubMed ID: 19010245
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of serum HLA antigens in allogeneic combinations.
Pellegrino MA; Indiveri F; Fagiolo U; Antonello A; Ferrone S
Transplantation; 1982 May; 33(5):530-3. PubMed ID: 6953687
[TBL] [Abstract][Full Text] [Related]
17. Adverse effect of blood transfusion on the long-term outcome of kidney transplantation.
Bućin D
Exp Clin Immunogenet; 1988; 5(1):39-47. PubMed ID: 3272814
[TBL] [Abstract][Full Text] [Related]
18. [Anti-HLA antibodies in nephropathic patients].
Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P
G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900
[TBL] [Abstract][Full Text] [Related]
19. Detection and specification of noncomplement binding anti-HLA alloantibodies.
Arnold ML; Zacher T; Dechant M; Kalden JR; Doxiadis II; Spriewald BM
Hum Immunol; 2004 Nov; 65(11):1288-96. PubMed ID: 15556679
[TBL] [Abstract][Full Text] [Related]
20. [Detection of common determinants of the HLA antigens A2 and B17 using absorption of immune human sera].
Májsky A; Korínková P
Cas Lek Cesk; 1983 Feb; 122(6):169-71. PubMed ID: 6187457
[No Abstract] [Full Text] [Related]
[Next] [New Search]
